BRZE vs PFE · rev $738.2M vs P/E 20, rev $15.03B
Braze Inc (BRZE) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Braze Inc (BRZE) is a software - application company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported BRZE revenue for 2026-01-31 was $738.2M. Net income was -$131.3M. Revenue was up 24.4% from 2025-01-31 to 2026-01-31. BRZE currently screens at market cap $3.27B.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
BRZE currently screens at market cap $3.27B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the BRZE and PFE stock pages for the full models.
Not investment advice.